Science Abstracts
RELATED CONTENT
NEWS
- UK govt offers "step change" in support for regenerative medicine
- Roche expands hepatitis C deal with Merck after Victrelis' EU nod
- 2011 US submission for Genentech/Curis' vismodegib in basal cell carcinoma
- AMAG, Allos to merge – but will it really bring sales synergies for Feraheme, Folotyn?

